Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2025-12-25 @ 3:39 AM
NCT ID: NCT02802202
Eligibility Criteria: Inclusion Criteria: * Control group: Individuals with no current or prior diagnosis consistent with Myofascial Pain Syndrome (MPS) or Fibromyalgia (FM). * MPS group: Individuals with a diagnosis of MPS that does not meet the American College of Rheumatology (ACR) diagnostic criteria for FM. * FM group: Individuals who met the criteria for a diagnosis of FM based upon the ACR diagnostic criteria. Exclusion Criteria: * Current neurologic conditions (e.g. Multiple Sclerosis) * Current metabolic conditions (e.g. Diabetic Neuropathy) * Current systemic conditions (e.g. Rheumatoid Arthritis) * Any skin or connective tissue problems (e.g. Marfan Syndrome) * Current symptoms of numbness, tingling, burning, coldness, or pain in your back, hands, or feet. * Any prior surgeries that may affect their ability to participate in this study. * A pacemaker or electrical implant that may be affected by electronic equipment. * Currently taking medications that may alter a subject's sensation or affect their ability to participate in this study. * Current shingles or post-herpetic neuralgia. * Current open skin wounds on your neck, arms, back, or legs * Current injuries at the designated palpation sites. * Currently having other medical conditions or limited function that might affect participation. * The ability to tolerate testing duration and procedures. * The ability to understand and complete all consent forms and questionnaires.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT02802202
Study Brief:
Protocol Section: NCT02802202